MBT
ALXN

Montecito Bank & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Montecito Bank & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,991
Closed -$366K – 263
2021
Q2 		$366K Hold
1,991
– – 0.07% 204
2021
Q1 		$304K Hold
1,991
– – 0.06% 213
2020
Q4 		$311K Sell
1,991
-735
-27% -$94.4K 0.07% 199
2020
Q3 		$312K Sell
2,726
-2,647
-49% -$286K 0.08% 165
2020
Q2 		$603K Sell
5,373
-27
-0.5% -$2.87K 0.17% 115
2020
Q1 		$485K Buy
5,400
+1,063
+25% +$104K 0.16% 116
2019
Q4 		$469K Buy
4,337
+1,102
+34% +$118K 0.13% 151
2019
Q3 		$317K Buy
+3,235
New +$365K 0.09% 175

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Montecito Bank & Trust's ALXN Position: Q3 2021 in Review

Montecito Bank & Trust sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,991 shares — an estimated $366K sold.

Montecito Bank & Trust first reported a position in ALXN in Q3 2019 and held it in 8 quarters. The position peaked at $603K in Q2 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Montecito Bank & Trust reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Montecito Bank & Trust sold 1,991 Alexion Pharmaceuticals shares in Q3 2021, an estimated $366K.
  • Montecito Bank & Trust first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 8 quarters.
  • Montecito Bank & Trust's Alexion Pharmaceuticals position peaked at $603K in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Montecito Bank & Trust's 13F filing for Q3 2021, filed 28 Oct 2021.